Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T19:11:32.926Z.
Calculation as of: 2026-10-06T19:11:32.926Z.
Quote observation: 2026-10-06T19:02:58.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 12cea9f103536ce45d7cd9f5ad4e572cb47010be1e9ba78d50bf2d4cf37a5898
PEG RATIO
N/A
DarioHealth Corp.
Market Cap
$45.05M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| DarioHealth Corp. (DRIO) | $45.05M | N/A |
| SANUWAVE Health Inc. (SNWV)vs › | $45.10M | N/A |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.16M | N/A |
| Celularity Inc. (CELU)vs › | $46.31M | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.60M | N/A |
| CVRx, Inc. (CVRX)vs › | $43.52M | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.14M | N/A |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.99M | N/A |
| Instil Bio, Inc. (TIL)vs › | $47.41M | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.81M | N/A |
PEG Ratio
N/A
P/E Ratio
8.9
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
